Pages that link to "Q36494275"

The following pages link to Effects of exogenous leptin on satiety and satiation in patients with lipodystrophy and leptin insufficiency (Q36494275):

Displaying 37 items.

• Role of leptin resistance in the development of obesity in older patients (Q26824127) (← links)
• Sleep Duration and Obesity in Adults: What Are the Connections? (Q30249186) (← links)
• Recombinant human leptin does not alter gut hormone levels after gastric bypass but may attenuate sweet cravings (Q30412152) (← links)
• Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight (Q34160218) (← links)
• Metreleptin: first global approval (Q34348966) (← links)
• Novel strategy for the use of leptin for obesity therapy (Q34454718) (← links)
• Low-affinity CCK-A receptors are coexpressed with leptin receptors in rat nodose ganglia: implications for leptin as a regulator of short-term satiety (Q34597722) (← links)
• Lipodystrophy: pathophysiology and advances in treatment (Q35148915) (← links)
• Repositioning leptin as a therapy for Alzheimer’s disease (Q35569809) (← links)
• Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin. (Q35578335) (← links)
• Pediatric obesity: etiology and treatment (Q35678445) (← links)
• Comparison of Efficacy and Safety of Leptin Replacement Therapy in Moderately and Severely Hypoleptinemic Patients with Familial Partial Lipodystrophy of the Dunnigan Variety (Q35869668) (← links)
• Clinical Features and Management of Non-HIV-Related Lipodystrophy in Children: A Systematic Review (Q36223346) (← links)
• Functional magnetic resonance imaging analysis of food-related brain activity in patients with lipodystrophy undergoing leptin replacement therapy (Q36293562) (← links)
• Clinical Effects of Long-Term Metreleptin Treatment in Patients With Lipodystrophy (Q36400947) (← links)
• Pharmacotherapy for childhood obesity: present and future prospects (Q36468087) (← links)
• Investigational therapies in the treatment of obesity (Q36543067) (← links)
• Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy (Q37062692) (← links)
• Metreleptin improves blood glucose in patients with insulin receptor mutations (Q37275992) (← links)
• The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline (Q37502548) (← links)
• Serum leptin and loss of control eating in children and adolescents (Q37510333) (← links)
• Therapeutic use of recombinant methionyl human leptin (Q37998711) (← links)
• Lipodystrophies: adipose tissue disorders with severe metabolic implications (Q38400624) (← links)
• Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives (Q38524414) (← links)
• Congenital generalized lipodystrophies--new insights into metabolic dysfunction (Q38560271) (← links)
• Pediatric obesity: etiology and treatment (Q42096028) (← links)
• Efficacy of leptin therapy in the different forms of human lipodystrophy (Q42632630) (← links)
• Enteroinsular hormones in two siblings with Donohue syndrome and complete leptin deficiency. (Q48046764) (← links)
• Perspective on the central control of appetite (Q48433953) (← links)
• Update on Therapeutic Options in Lipodystrophy (Q58102297) (← links)
• Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities (Q58578562) (← links)
• Efficacy of Metreleptin Treatment in Familial Partial Lipodystrophy Due to PPARG vs LMNA Pathogenic Variants. (Q64905660) (← links)
• Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy (Q88556380) (← links)
• Early-life programming of adipose tissue (Q89959164) (← links)
• Current Diagnosis, Treatment and Clinical Challenges in the Management of Lipodystrophy Syndromes in Children and Young People (Q92754315) (← links)
• Leptin's hunger-suppressing effects are mediated by the hypothalamic-pituitary-adrenocortical axis in rodents (Q92859815) (← links)
• Familial Partial Lipodystrophy (FPLD): Recent Insights (Q95642157) (← links)